155 related articles for article (PubMed ID: 8856498)
1. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
2. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of the human MSH receptor in a mouse melanoma cell line.
Chluba-de Tapia J; Bagutti C; Wikberg JS; Chhajlani V; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):43-53. PubMed ID: 8903930
[TBL] [Abstract][Full Text] [Related]
4. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.
Solca FF; Chluba-de Tapia J; Iwata K; Eberle AN
FEBS Lett; 1993 May; 322(2):177-80. PubMed ID: 8482388
[TBL] [Abstract][Full Text] [Related]
5. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
6. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
7. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
8. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines.
Siegrist W; Stutz S; Eberle AN
Cancer Res; 1994 May; 54(10):2604-10. PubMed ID: 8168086
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
[TBL] [Abstract][Full Text] [Related]
10. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
Graham A; Wakamatsu K; Hunt G; Ito S; Thody AJ
Pigment Cell Res; 1997 Oct; 10(5):298-303. PubMed ID: 9359625
[TBL] [Abstract][Full Text] [Related]
11. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
12. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the regulation of pigmentation in alpha-melanocyte-stimulating hormone responsive and unresponsive cultured B16 melanoma cells.
Hill SE; Buffey J; Thody AJ; Oliver I; Bleehen SS; Mac Neil S
Pigment Cell Res; 1989; 2(3):161-6. PubMed ID: 2549531
[TBL] [Abstract][Full Text] [Related]
14. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
15. In situ melanin assay for MSH using mouse B16 melanoma cells in culture.
Siegrist W; Eberle AN
Anal Biochem; 1986 Nov; 159(1):191-7. PubMed ID: 3812999
[TBL] [Abstract][Full Text] [Related]
16. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
17. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
18. Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis.
Hunt G; Thody AJ
J Endocrinol; 1995 Nov; 147(2):R1-4. PubMed ID: 7490543
[TBL] [Abstract][Full Text] [Related]
19. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ.
Tatro JB; Entwistle ML; Lester BR; Reichlin S
Cancer Res; 1990 Feb; 50(4):1237-42. PubMed ID: 2153454
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
